Date: Monday 22nd August
Time: 7.00am to 8.00am
Title: In Acromegaly, CONTROL IS CRITICAL
Content: Uncontrolled biochemical levels in acromegaly may increase mortality. 45% of patients treated with first generation SSAs remain uncontrolled. Next generation treatment options are now available that help achieve biochemical control and tumour volume shrinkage.
Topic 1: Uncontrolled biochemical control in Acromegaly and associated co-morbidities
Topic 2: Signifor LAR (Pasreotide) in patients with inadequately controlled Acromegaly
Speakers: Professor Ken Ho and Dr Ann McCormack
This Breakfast Session is complimentary, however you must sign up for it via your conference registration here.
This session is supported and organised by